Nanoparticle-Based Vaccine Delivery for Cancer Immunotherapy

키워드

참고문헌 (46)

1. Craparo, E. F., "Application of polymeric nanoparticles in immunotherapy", Curr. Opin. Allergy Clin. Immunol, 12, pp.658~664 (2012)
2. Smith, D. M., "Applications of nanotechnology for immunology", Nat. Rev. Immunol, 13, pp.592~605 (2013)
3. Serda, R. E, "Particle platforms for cancer immunotherapy", Int. J. Nanomedicine, 8, pp.1683~1696 (2013)
4. Rodriguez-Limas, W. A, "Virus-like particles: the future of microbial factories and cell-free systems as platforms for vaccine development", Curr. Opin. Biotechnol (2013)
5. Yuba, E., "A liposome-based antigen delivery system using pH-sensitive fusogenic polymers for cancer immunotherapy", Biomaterials, 34, pp.3042~3052 (2013)
6. Syed, S., "Immune response to nanomaterials: implications for medicine and literature review", Curr. Allergy. Asthma Rep, 13, pp.50~57 (2013)
7. Ditto, A. J., "Non-viral gene delivery using nanoparticles", Expert. Opin. Drug Deliv, 6, pp.1149~1160 (2009)
8. Hua, S, "Targeted nanoparticles that mimic immune cells in pain control inducing analgesic and anti-inflammatory actions: a potential novel treatment of acute and chronic pain condition", Pain Physician, 16, pp.E199~E216 (2013)
9. Gregory, A. E., "Vaccine delivery using nanoparticles", Front Cell Infect. Microbiol, 3, pp.1~13 (2013)
10. Hadinoto, K, "Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: A review", Eur. J. Pharm. Biopharm (2013)
11. Pawar, D., "Development and characterization of surface modified PLGA nanoparticles for nasal vaccine delivery: Effect of mucoadhesive coating on antigen uptake and immune adjuvant activity", Eur. J. Pharm. Biopharm (2013)
12. DeMuth, P. C., "Releasable layer-by-layer assembly of stabilized lipid nanocapsules on microneedles for enhanced transcutaneous vaccine delivery", ACS Nano, 6, pp.8041~8051 (2012)
13. 이준식, "Deoxypodophyllotoxin Induces a Th1 Response and Enhances the Antitumor Efficacy of a Dendritic Cell-based Vaccine", Immune Network, 11(1), pp.79~94 (2011), 대한면역학회
14. 노경태, "The Mycobacterium avium subsp. paratuberculosis fibronectin attachment protein, a toll-like receptor 4 agonist, enhances dendritic cell-based cancer vaccine potency", Experimental and Molecular Medicine, 44(5), pp.340~349 (2012), 생화학분자생물학회
15. Cho, N. H., "A multifunctional core-shell nanoparticle for dendritic cell-based cancer immunotherapy", Nat. Nanotechnol, 6, pp.675~682 (2011)
16. Noh, Y. W., "Polymer nanomicelles for efficient mucus delivery and antigen-specific high mucosal immunity", Angew. Chem. Int. Ed. Engl, 52, pp.7684~7689 (2013)
17. Prasad, S., "Polymer nanoparticles containing tumor lysates as antigen delivery vehicles for dendritic cell-based antitumor immunotherapy", Nanomedicine, 7, pp.1~10 (2011)
18. Silva, J. M., "Immune system targeting by biodegradable nanoparticles for cancer vaccines", J. Control. Release, 168, pp.179~199 (2013)
19. Xiang, S. D., "Methods of effective conjugation of antigens to nanoparticles as non-inflammatory vaccine carriers", Methods, 60, pp.232~241 (2013)
20. Nembrini, C., "Nanoparticle conjugation of antigen enhances cytotoxic T-cell responses in pulmonary vaccination", Proc. Natl. Acad. Sci. USA, 108, pp.E989~E997 (2011)
21. Andrade, F., "Nanotechnology and pulmonary delivery to overcome resistance in infectious diseases", Adv. Drug Deliv. Rev (2013)
22. Suh, W. H., "Nanotechnology, nanotoxicology, and neuroscience", Prog. Neurobiol, 87, pp.133~170 (2009)
23. Zhang, L., "Nanoparticles in medicine: therapeutic applications and developments", Clin. Pharmacol. Ther, 83, pp.761~769 (2008)
24. Kotagiri, N., "Selective pathogen targeting and macrophage evading carbon nanotubes through dextran sulfate coating and PEGylation for photothermal theranostics", J. Biomed. Nanotechnol, 9, pp.1008~1016 (2013)
25. Kanekiyo, M., "Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies", Nature, 499, pp.102~106 (2013)
26. Perry, J. L., "PEGylated PRINT nanoparticles: the impact of PEG density on protein binding, macrophage association, biodistribution, and pharmacokinetics", Nano Lett, 12, pp.5304~5310 (2012)
27. Kim, J. H., "Multifunctional hybrid nanoconjugates for efficient in vivo delivery of immunomodulating oligonucleotides and enhanced antitumor immunity", Angew. Chem. Int. Ed. Engl, 51, pp.9670~9673 (2012)
28. Demento, S. L., "Inflammasomeactivating nanoparticles as modular systems for optimizing vaccine efficacy", Vaccine, 27, pp.3013~3021 (2009)
29. Diwan, M., "Enhancement of immune responses by co-delivery of a CpG oligodeoxynucleotide and tetanus toxoid in biodegradable nanospheres", J. Control. Release, 85, pp.247~262 (2002)
30. Clawson, C., "Delivery of a peptide via poly(D,L-lactic-co-glycolic) acid nanoparticles enhances its dendritic cell-stimulatory capacity", Nanomedicine, 6, pp.651~661 (2010)
31. Shen, H., "Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles", Immunology, 117, pp.78~88 (2006)
32. Liu, S. Y., "Nanoparticles-based multi-adjuvant whole cell tumor vaccine for cancer immunotherapy", Biomaterials, 34, pp.8291~8300 (2013)
33. Shima, F., "Manipulating the antigen-specific immune response by the hydrophobicity of amphiphilic poly(gamma-glutamic acid) nanoparticles", Biomaterials, 34, pp.9709~9716 (2013)
34. Reddy, S. T., "Exploiting lymphatic transport and complement activation in nanoparticle vaccines", Nat. Biotechnol, 25, pp.1159~1164 (2007)
35. Bachmann, M. F., "Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns", Nat. Rev. Immunol, 10, pp.787~796 (2010)
36. Foged, C., "Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model", Int. J. Pharm, 298, pp.315~322 (2005)
37. Mottram, P. L., "Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus", Mol. Pharm, 4, pp.73~84 (2007)
38. Thurn, K. T., "Nanoparticles for applications in cellular imaging", Nanoscale Res. Lett, 2, pp.430~441 (2007)
39. Yan, W., "Reactive oxygen species play a central role in the activity of cationic liposome based cancer vaccine", J. Control. Release, 130, pp.22~28 (2008)
40. Venkataraman, S., "The effects of polymeric nanostructure shape on drug delivery", Adv. Drug Deliv. Rev, 63, pp.1228~1246 (2011)
41. Florez, L., "How shape influences uptake: interactions of anisotropic polymer nanoparticles and human mesenchymal stem cells", Small, 8, pp.2222~2230 (2012)
42. Alexis, F., "Factors affecting the clearance and biodistribution of polymeric nanoparticles", Mol. Pharm, 5, pp.505~515 (2008)
43. Kelly, C., "Targeted liposomal drug delivery to monocytes and macrophages", J. Drug Deliv, 2011, pp.727241~ (2011)
44. Nguyen, D. N., "Lipid-derived nanoparticles for immunostimulatory RNA adjuvant delivery", Proc. Natl. Acad. Sci. USA, 109, pp.E797~E803 (2012)
45. Geissmann, F., "Blood monocytes consist of two principal subsets with distinct migratory properties", Immunity, 19, pp.71~82 (2003)
46. Lee, I. H., "Imageable antigen-presenting gold nanoparticle vaccines for effective cancer immunotherapy in vivo", Angew. Chem. Int. Ed. Engl, 51, pp.8800~8805 (2012)

관련 논문AI추천